← Eichor
Study identifier: NCT05730244 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor

Condition: Tinea Versicolor · Pityriasis Versicolor  ·  Sponsor: The University of The West Indies

PhasePhase 1
Planned participants20
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to establish the efficacy of Cassia alata extract as a cream form in treating tinea versicolor (liver spots/shifting clouds). The main questions the study aims to answer are:• Does the use of this extract help resolve tinea versicolor better than no treatment? Does the use of this cream have significant side effects i.e, is it safe? Participants will be asked to treat a designated area while leaving additional areas untreated. 1-2 finger tip units of cream will be applied to the treatment site twice daily at least 8 hours apart. Participants will attend the trial clinic every 4 weeks for 12 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Marvin Reid, MB Bs PhD  ·  8763812939  ·  marvin.reid@uwimona.edu.jm

Always discuss trial participation with your own doctor first.

Locations (1)

University of the West Indies, MonaKingston, Other, JamaicaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05730244